A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates
- 1 April 2005
- Vol. 23 (22) , 2893-2901
- https://doi.org/10.1016/j.vaccine.2004.11.064
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education of the People's Republic of China
- Science and Technology Projects of Fujian Province (2002 F013)
This publication has 15 references indexed in Scilit:
- Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid proteinVaccine, 2005
- Evaluation of antibody‐based and nucleic acid‐based assays for diagnosis of hepatitis E virus infection in a rhesus monkey modelJournal of Medical Virology, 2003
- Hepatitis E virusReviews in Medical Virology, 2003
- Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaquesVaccine, 2002
- Report of a Collaborative Study to Assess the Suitability of a Reference Reagent for Antibodies to Hepatitis E VirusBiologicals, 2002
- Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non‐A, ‐B, and ‐C acute hepatitisJournal of Medical Virology, 2001
- Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural proteinJournal of Medical Virology, 2001
- Structural Characterization of Recombinant Hepatitis E Virus ORF2 Proteins in Baculovirus-Infected Insect CellsProtein Expression and Purification, 1998
- Recombinant vaccine against hepatitis E: dose response and protection against heterologous challengeVaccine, 1997
- Properties and classification of hepatitis A virusVaccine, 1992